Nbryo Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $12.7M

  • Investors
  • 5

Nbryo General Information

Description

Developer of cattle breeding technology designed for the livestock industries to improve production efficiency. The company offers a biotechnology system with genetic selection, in vitro embryo production, embryo transfer, preservation, logistics, and data analysis capabilities to accelerate genetic improvement and improve productivity in beef and dairy production, enabling cattle breeders to select desirable traits, improve herd genetics, reduce breeding costs, and support productive and sustainable livestock production.

Contact Information

Website
www.nbryo.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Care of Building 1, Freeway Office Park
  • 2728 Logan Road, Eight Mile Plains
  • Brisbane, Queensland 4113
  • Australia
+61 (07)
Primary Industry
Animal Husbandry
Other Industries
Other Agriculture
Biotechnology
Corporate Office
  • Care of Building 1, Freeway Office Park
  • 2728 Logan Road, Eight Mile Plains
  • Brisbane, Queensland 4113
  • Australia
+61 (07)

Nbryo Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nbryo Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 16-Mar-2026 $12.7M Completed Generating Revenue
2. Seed Round 17-Sep-2024 Completed Generating Revenue
1. Seed Round 01-Jan-2023 Completed Startup
To view Nbryo’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Nbryo Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nbryo Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
AgriZeroNZ Impact Investing Minority
Gates Foundation Not-For-Profit Venture Capital Minority
QIC Sovereign Wealth Fund Minority
Mandalay VC Venture Capital Minority
Tenacious Ventures Venture Capital Minority
To view Nbryo’s complete investors history, request access »

Nbryo FAQs

  • When was Nbryo founded?

    Nbryo was founded in 2020.

  • Where is Nbryo headquartered?

    Nbryo is headquartered in Brisbane, Australia.

  • What is the size of Nbryo?

    Nbryo has 21 total employees.

  • What industry is Nbryo in?

    Nbryo’s primary industry is Animal Husbandry.

  • Is Nbryo a private or public company?

    Nbryo is a Private company.

  • What is Nbryo’s current revenue?

    The current revenue for Nbryo is .

  • How much funding has Nbryo raised over time?

    Nbryo has raised $25M.

  • Who are Nbryo’s investors?

    AgriZeroNZ, Gates Foundation, QIC, Mandalay VC, and Tenacious Ventures have invested in Nbryo.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process